Vildagliptin / Metformin hydrochloride Accord 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Eucreas 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Zomarist 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - farmaci usati nel diabete - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Vildagliptin Zentiva 50 mg Tabletten Vildagliptin Zentiva 50 mg Tabletten 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

vildagliptin zentiva 50 mg tabletten vildagliptin zentiva 50 mg tabletten

helvepharm ag - vildagliptinum - vildagliptin zentiva 50 mg tabletten - vildagliptinum 50 mg, lactosum 136 mg, carboxymethylamylum natricum a corresp. natrium 0.336 - 0.504 mg, magnesii stearas, pro compresso. - il diabete mellito di tipo 2 - synthetika